Body image distortion is an important problem in physical and psychological health in adolescents. This study examined the factors affecting body image distortion in Korean adolescents. A Rao–Scott χ² test and a complex samples logistic regression was conducted using the statistics from the 17th (2021) Korea Youth Risk Behavior Web-based Survey. The study sample included 41,124 middle and high school students. There was a difference in the presence or absence of body image distortion according to the subject’s gender, school grade, school achievement, and economic status (p < 0.001). Approximately 49.5% of subjects with body image distortion had tried to lose weight, but there were few cases where they attempted to lose weight through physical activities, such as moderate physical activity (22.8%), vigorous physical activity (23.3%), and muscle physical activity (23.9%) (p < 0.001). The group with body image distortion was 1.77 times more likely to sit for more than four hours a day on average (p < 0.001). To prevent various factors influencing the distortion of the adolescent’s body image, the development of a systematic intervention program for forming no distortion of adolescents’ body image is required.

This study examined the factors related to eating disorders (ED) and the relationship between ED and subjective health or subjective oral health in adolescents. The 46,146 adolescents (age 12–18 years) who participated in the Korea Youth Risk Behavior Web-based Survey were selected, including those who had attempted to lose weight within the past 30 days during the survey period. The variables included were eating behavior, BMI, body image subjective health, and subjective oral health. The weight-loss method was divided into two groups (regular exercise, RE, and eating disorder, ED). The data were analyzed using the Rao-Scott χ² test and logistic regression analysis. The adolescents with an obese body image had a lower risk of ED (OR = 0.75, 95% CI 0.38–1.49) than adolescents with a very thin body image. Adolescents with ED had a higher risk of a poor subjective health assessment (OR = 2.32, 95% CI 1.85–2.91). On the other hand, they had a lower risk of a poor subjective oral health assessment (OR = 0.89, 95% CI 0.71–1.12). ED is closely associated with eating behavior, BMI, body image, oral health behavior, subjective health, and subjective oral health in Korean adolescents.

A-Reum Kang, Su-Hee Park, Jung-Woong Woo, Da-Jung Hong, Kyu-Ri Kim, Chi-Yeong Sung, Ji-Yeon Woo, Ju-Hui Jeong, and Eun-Ha Jung. J Dent Hyg Sci 2020;20:9-15. https://doi.org/10.17135/jdhs.2020.20.1.9

Background/Objectives: Dental plaque, a biofilm composed of accumulated oral microorganisms, is a key contributor to various oral diseases. 6-shogaol, a bioactive compound of ginger, is known to have pharmacological activities, including anticancer, anti-inflammatory, and antimicrobial activities. Therefore, we aimed to determine the effects of 6-shogaol on dual-species biofilms of Streptococcus mutans (S. mutans) and Candida albicans (C. albicans). Methods: Dual-species oral biofilms were formed on hydroxyapatite (HA) disks for 42 h and exposed to 6-shogaol. The pH was measured in the experimental medium, and the biomass, colony-forming unit (CFU) of microbial cells, and insoluble extracellular polysaccharides (EPS) were quantified in the biofilm formed on the HA disk. Confocal laser scanning microscopy (CLSM) was used to assess biofilm morphology, and quantitative polymerase chain reaction was performed to analyze gtf gene expression. Results: 6-shogaol dose-dependently reduced insoluble EPS, CFU counts, and dry weight of biofilms. The pH was maintained above 5.5 in the 6-shogaol-treated group. CLSM images showed that S. mutans proliferation, C. albicans hyphal development, and EPS production were markedly inhibited in biofilms treated with 6-shogaol. The expression of gtfB and gtfC was significantly downregulated by 6-shogaol. Conclusions: These findings suggest that 6-shogaol has the potential to be a promising natural product for the prevention and management of oral biofilm-related oral diseases.